Antipsychotic-resistant delusions are common in schizophrenia and are frequently responsible for incarceration and self injury. Converging evidence from cognitive neuroscience suggests that delusions persist due to an inability to extinguish or unlearn the false belief; a failure to activate ventromedial prefrontal cortex durig memory consolidation appears to play a role in this deficit. D-cycloserine is a highly potent full agonist at a subpopulation of NMDA receptors involved in memory consolidation and robustly enhances memory consolidation in fear extinction models and when combined with CBT in anxiety disorders. We have demonstrated improvement of memory consolidation with D-cycloserine in schizophrenia and, in a pilot trial, demonstrated a large effect on delusional severity and distress when combined with two sessions of CBT employing an alternative beliefs exercise. We now propose a parallel-group, placebo-controlled trial of once-weekly D-cycloserine augmentation of a 12 session CBT treatment for persistent delusions in 60 schizophrenia subjects with follow-up at 3 and 6 months. In addition to assessing and characterizing response of delusions, this study will clarify time course of effect and examine cognitive factors that may mediate D-cycloserine's effect, including enhancement of memory consolidation and of cognitive flexibility. This study will provide data necessary to design and implement a larger, definitive trial that could fundamentally alter the treatment approach to refractory delusions while providing an important clinical test for a compelling new model for delusions.

Public Health Relevance

Delusions are frequently unresponsive to current treatments, are often responsible for hospitalization, and can lead to considerable suffering. This project follows from compelling new evidence from cognitive neuroscience linking delusions to an inability to 'unlearn' false beliefs- by combining D-cycloserine, which enhances learning, with cognitive behavioral therapy, we believe we can help individuals recover from the burden of delusions and lead much more satisfying lives.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Planning Grant (R34)
Project #
4R34MH100296-03
Application #
8896060
Study Section
Interventions Committee for Adult Disorders (ITVA)
Program Officer
Morris, Sarah E
Project Start
2013-08-05
Project End
2017-01-31
Budget Start
2016-03-01
Budget End
2017-01-31
Support Year
3
Fiscal Year
2016
Total Cost
Indirect Cost
Name
New York University
Department
Psychiatry
Type
Schools of Medicine
DUNS #
121911077
City
New York
State
NY
Country
United States
Zip Code
10016